| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $145.2M | -0.5% |
| R&D Expense | $143.2M | +3.2% |
| SG&A Expense | $115.4M | -12.5% |
| Operating Income | -$119.4M | +7.8% |
| Pre-tax Income | -$76.4M | +46.5% |
| Income Tax | $57K | -82.4% |
| Net Income | -$76.4M | +46.6% |
| EPS (Basic) | -$0.63 | +49.6% |
| EPS (Diluted) | -$0.93 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62.5M | +19.6% |
| Accounts Receivable | $30.8M | +14.1% |
| Inventory | $4.7M | +55.7% |
| Current Assets | $156.5M | -33.1% |
| Total Assets | $164.4M | -31.6% |
| Current Liabilities | $92.3M | +32.8% |
| Total Liabilities | $350.4M | -7.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$127.5M | -37.5% |
| Capital Expenditures | $142K | — |
| Investing Cash Flow | $95.5M | +1102.4% |
| Financing Cash Flow | $41.6M | +3605.2% |
| Free Cash Flow | -$127.6M | -37.6% |
| +25.6% |
| Stockholders' Equity |
| -$186.0M |
| -36.6% |